>
pdufa.bio

Tecovirimat Oral

Updated ยทnext FDA decision on the calendar

Tecovirimat Oral is a Siga Technologies Inc program. Its next catalyst is a Readout in Jan 2027. Every date links its source.

SIGA catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Siga Technologies Inc (SIGA). We track 1 catalyst event for this program: 1 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Jan 2027SIGA

Questions

When is Tecovirimat Oral's next FDA decision or readout?

The next tracked catalyst for Tecovirimat Oral is a Readout in Jan 2027.

What happened at Tecovirimat Oral's most recent FDA decision?

No FDA decision for Tecovirimat Oral is in our archive yet.

Who makes Tecovirimat Oral?

Siga Technologies Inc (SIGA).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.